Qube Research & Technologies (QRT)
INO icon

Qube Research & Technologies (QRT)’s Inovio Pharmaceuticals INO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,651
Closed -$25.5K – 3768
2026
Q1 		$25.5K Sell
14,651
-100,819
-87% -$166K ﹤0.01% 3253
2025
Q4 		$201K Buy
115,470
+81,974
+245% +$181K ﹤0.01% 3059
2025
Q3 		$78.4K Sell
33,496
-81,668
-71% -$156K ﹤0.01% 3110
2025
Q2 		$234K Buy
+115,164
New +$221K ﹤0.01% 2874
2025
Q1 		– Sell
-35,431
Closed -$64.8K – 3676
2024
Q4 		$64.8K Buy
35,431
+23,742
+203% +$105K ﹤0.01% 3060
2024
Q3 		$67.6K Sell
11,689
-67,590
-85% -$558K ﹤0.01% 2804
2024
Q2 		$641K Buy
79,279
+1,576
+2% +$16.6K ﹤0.01% 2063
2024
Q1 		$1.08M Buy
+77,703
New +$671K ﹤0.01% 2104
2023
Q4 		– Sell
-4,855
Closed -$22.7K – 4524
2023
Q3 		$22.7K Sell
4,855
-73,828
-94% -$408K ﹤0.01% 3117
2023
Q2 		$422K Buy
78,683
+45,827
+139% +$369K ﹤0.01% 1560
2023
Q1 		$323K Buy
+32,856
New +$560K ﹤0.01% 1724
2022
Q4 		– Sell
-8,011
Closed -$166K – 2726
2022
Q3 		$166K Sell
8,011
-9,220
-54% -$236K ﹤0.01% 1825
2022
Q2 		$358K Buy
17,231
+15,169
+736% +$428K ﹤0.01% 1532
2022
Q1 		$89K Sell
2,062
-5,188
-72% -$234K ﹤0.01% 2096
2021
Q4 		$434K Buy
+7,250
New +$581K ﹤0.01% 1633
2020
Q1 		– Sell
-850
Closed -$34K – 1395
2019
Q4 		$34K Buy
+850
New +$25.6K ﹤0.01% 1491

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Inovio Pharmaceuticals (INO) in Q2 2026, closing a stake of 14,651 shares — an estimated $25.5K sold.

Qube Research & Technologies (QRT) first reported a position in INO in Q4 2019 and held it in 16 quarters. The position peaked at $1.08M in Q1 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Inovio Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,651 Inovio Pharmaceuticals shares in Q2 2026, an estimated $25.5K.
  • Qube Research & Technologies (QRT) first reported a position in Inovio Pharmaceuticals in Q4 2019 and held it in 16 quarters.
  • Qube Research & Technologies (QRT)'s Inovio Pharmaceuticals position peaked at $1.08M in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.